Ensysce Biosciences (ENSC) Non-Current Assets (2017 - 2025)
Ensysce Biosciences' Non-Current Assets was $207,461 in Q4 2025, down 17.9% from $252,550 a year earlier and down 17.4% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Non-Current Assets (2017 - 2025) Analysis & Trends
From Q4 2017 onward, Ensysce Biosciences has reported Non-Current Assets for 33 quarters.
- Non-Current Assets has now declined for four consecutive years, though with a five-year compound annual growth rate of 121.0% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $252,550 in FY2024 (-39.8%), $419,217 in FY2023 (-28.4%), $585,883 in FY2022 (-22.4%) and $754,756 in FY2021.
- The Q4 2025 figure marks the lowest quarterly Non-Current Assets since Q4 2020.
- Compared with a year earlier, Non-Current Assets has declined for 16 straight quarters, with an average decline of 28.6% over the last eight quarters.
- Over the past five years, the year-over-year decline in Non-Current Assets ranged from 10.0% (Q2 2022) to 94.4% (Q1 2022).
- Per Business Quant data, ENSC's Non-Current Assets in the three quarters before Q4 2025 was $251,194 (Q3 2025), $292,860 (Q2 2025) and $210,883 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Ensysce Biosciences | 1.30 Mn | -9.94 Mn | - | 207,461.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 207,461.00 |
| Sep 30, 2025 | 251,194.00 |
| Jun 30, 2025 | 292,860.00 |
| Mar 31, 2025 | 210,883.00 |
| Dec 31, 2024 | 252,550.00 |
| Sep 30, 2024 | 294,217.00 |
| Jun 30, 2024 | 335,883.00 |
| Mar 31, 2024 | 377,550.00 |
| Dec 31, 2023 | 419,217.00 |
| Sep 30, 2023 | 460,883.00 |
| Jun 30, 2023 | 502,550.00 |
| Mar 31, 2023 | 544,217.00 |
| Dec 31, 2022 | 585,883.00 |
| Sep 30, 2022 | 627,550.00 |
| Jun 30, 2022 | 754,242.00 |
| Mar 31, 2022 | 713,090.00 |
| Dec 31, 2021 | 754,756.00 |
| Sep 30, 2021 | 796,423.00 |
| Jun 30, 2021 | 838,141.00 |
| Mar 31, 2021 | 12.75 Mn |
API Access
Ensysce Biosciences Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();